RECENT NEWS

On behalf of the biomedical science profession, the IBMS has submitted its response to the change.NHS Consultation, shaping the 10-Year Health Plan.

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the US to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease.

The Liverpool City Region Innovation Zone Programme has launched a new business support centre to commercialise businesses in health and life science research, backed by the Liverpool City Region Combined Authority.

Complete Genomics, a California-based genomic sequencer manufacturer, has announced the launch of its mpox virus (MPXV) amplicon sequencing panel, part of its sequencing product portfolio for pathogenic microorganisms.

International medical imaging IT and cybersecurity company Sectra’s digital pathology solution will be adopted by the hospital CH Béziers in France. It is the third hospital in the region to choose Sectra, providing it with a powerful platform for collaboration.

To mark World Antimicrobial Awareness Week, The Royal College of Pathologists (RCPath) has published its recommendations for the UK government and NHS to support medical microbiologists and virologists.

Roche has announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies.

Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, has expanded its range of products for scientists seeking to harness the utility of the GFP (green fluorescent protein) tag.

Revvity has announced an expansion of its work with Genomics England that leverages both organisations' expertise and resources to advance critical genomic initiatives across the United Kingdom.

Glox Therapeutics has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.

Biotech firm Owkin and AI-enabled pathology solutions company Proscia have announced a strategic partnership to streamline MSI testing for patients with colorectal cancer (CRC), the second most deadly cancer worldwide.

With whooping cough cases on the rise in many areas around the world, a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.

Genomics company Biofidelity has announced the launch of Aspyre Lung reagents for liquid biopsy samples. Aspyre Lung identifies established non-small cell lung cancer (NSCLC) biomarkers in both DNA and RNA from tissue and blood in a single straightforward, four-step workflow and runs on existing qPCR platforms, enabling simple integration into laboratories globally.

Linkam Scientific Instruments has announced new updates to its specialist CMS196 cryo-stage. The CMS196V4 supports cryo-correlative light and electron microscopy (cryo-CLEM) and allows researchers to investigate samples at cryogenic temperatures down to < -195 °C.

Abbott has marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony attended by Taoiseach Simon Harris and Abbott Chairman and Chief Executive Officer Robert Ford. The site is a global manufacturing centre of excellence for Abbott's diabetes care business and will employ more than 800 people.

Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a strategic collaboration with AstraZeneca, a leading pharmaceutical company, to develop AI-powered digital pathology solutions for rapid and convenient prediction of non-small cell lung cancer driver mutations (NSCLC).

Mast Group has been selected for the Innovate UK Global Business Innovation Programme (GBIP) focused on Antimicrobial Resistance (AMR) in Sweden. The programme is designed to help UK businesses to grow and scale on a global stage through building R&D and innovation collaborations and partnerships.

bioMérieux, a world leader in the field of in vitro diagnostics, has announced its first Data & IT Centre of Reference partnership with St James's Hospital, Ireland. This landmark collaboration was celebrated with a hybrid event held at the Davis Coakley Lecture Theatre, St James's Hospital, Dublin on 14 November, marking a historic milestone for bioMérieux.

National surveillance data published by the UK Health Security Agency show that antibiotic-resistant infections in 2023 surpassed pre-pandemic levels. There were an estimated 66,730 serious antibiotic-resistant infections in 2023, compared to 62,314 in 2019.

​The Medicines and Healthcare products Regulatory Agency (MHRA) has launcjed a consultation on proposed changes to the regulatory requirements a medical device (including IVDs) must meet before it is placed on the market in Great Britain. The consultation will close on 5 January 2025.